Infectious Diseases (all articles)
Systematic Review: Plasma from People who Have Recovered from COVID-19 to Treat Individuals with COVID-19
15 May, 2020 | 03:48h | UTC
Study: Airborne Lifetime of Small Speech Droplets and their Potential Importance in SARS-CoV-2 Transmission
15 May, 2020 | 03:43h | UTCCommentaries: Expert reaction to study looking at speech-generated droplets and COVID-19 transmission – Science Media Centre AND Loud Talking Can Spread More than 1,000 Coronavirus Particles in the Air for 14 Minutes: Study – The Science Times AND Simply talking in confined spaces may be enough to spread the coronavirus, researchers say – USA Today AND Loud talking could leave coronavirus in the air for up to 14 minutes – MIT Technology Review
Opinion: Masks Help Stop the Spread of Coronavirus
15 May, 2020 | 03:44h | UTCRelated: Face Masks Against COVID-19: An Evidence Review – Preprints AND Face Masks for the Public During the Covid-19 Crisis
ACP Systematic Review: Chloroquine or Hydroxychloroquine Alone or in Combination with Azithromycin for the Prophylaxis or Treatment of COVID-19
15 May, 2020 | 03:32h | UTC
Study Commentary: Before/after Study of Short-Course Steroid in COVID-19
14 May, 2020 | 10:09h | UTCBefore/after study of short-course steroid in COVID-19 – PulmCrit
Original Study (Preprint): Early Short Course Corticosteroids in Hospitalized Patients with COVID-19 – medRxiv
Meta-Analysis: Manifestations and Prognosis of Gastrointestinal and Liver Involvement in COVID-19
14 May, 2020 | 10:16h | UTCRelated: Gastrointestinal, Hepatobiliary, and Pancreatic Manifestations of COVID-19 (review and guideline) AND Abdominal Imaging Findings in COVID-19: Preliminary Observations – Radiology
New Study Does Not Support the Idea that BCG Vaccination Protects Against COVID-19
14 May, 2020 | 10:12h | UTCSARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults – JAMA
Related: BCG Against Coronavirus: Less Hype And More Evidence, Please – Forbes AND Does BCG vaccination protect against acute respiratory infections and COVID-19? A rapid review of current evidence – CEBM University of Oxford AND Bacille Calmette-Guérin (BCG) vaccination and COVID-19 – World Health Organization
Estimating Excess Deaths Associated with the COVID-19 According to Underlying Conditions and Age
14 May, 2020 | 10:05h | UTCCommentaries: Scientists develop online calculator to predict individual’s risk of dying from Covid-19 – The Independent AND Expert reaction to study estimating excess deaths over one year directly or indirectly related to COVID-19 based on underlying health conditions and age of UK population, and making comments on the effect of easing the lockdown – Science Media Centre
See calculator: OurRisk.CoV
Related Commentary on Twitter
NEW—Estimating excess 1-year mortality associated with the #COVID19 pandemic according to underlying conditions and age: a population-based cohort study https://t.co/ryAyF5x9EG (1/3) @ucl @uclh @NHSBartsHealth @GreatOrmondSt @UniofOxford @turinginst @MRC_Epid @HDR_UK @PHE_uk pic.twitter.com/UPkz8410CC
— The Lancet (@TheLancet) May 12, 2020
Coronavirus Test Shortages Trigger a New Strategy: Group Screening
14 May, 2020 | 09:53h | UTCCoronavirus Test Shortages Trigger a New Strategy: Group Screening – Scientific American
Related: Pooling of Samples for Testing for SARS-CoV-2 in Asymptomatic People (studies and commentaries) AND Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2 – JAMA Network
Systematic Review: SARS-CoV-2 (COVID-19) and Children
14 May, 2020 | 02:33h | UTCRelated Systematic Review: SARS-CoV-2 Infection in Children and Adolescents (study and commentaries)
Interpreting a Covid-19 Test Result
13 May, 2020 | 02:18h | UTCPractice Pointer: Interpreting a covid-19 test result – The BMJ
Related: Interpreting Diagnostic Tests for SARS-CoV-2 – JAMA
Editorial: Waste in Covid-19 Research
13 May, 2020 | 02:17h | UTCWaste in covid-19 research – The BMJ
Related Landmark Paper from the Author: Avoidable waste in the production and reporting of research evidence – The Lancet (free registration required)
Related Commentary on Twitter
"A deluge of poor quality research is sabotaging an effective evidence based response" say @PaulGlasziou, Sharon Sanders and @Tammy_Hoffmann https://t.co/jvx8FQxQCo
— The BMJ (@bmj_latest) May 12, 2020
New Clinical Risk Score to Predict the Occurrence of Critical Illness in Hospitalized Patients With COVID-19
13 May, 2020 | 02:14h | UTCSee also: Calculation Tool For Predicting Critical-ill COVID-19 At Admission
Related Preprint Study (just published): Development and validation of the COVID-19 severity index (CSI): a prognostic tool for early respiratory decompensation – medRxiv AND Calculation Tool: https://covidseverityindex.org/
Study: A Close Relative of SARS-CoV-2 Found in Bats Offers More Evidence It Evolved Naturally
13 May, 2020 | 02:08h | UTCA close relative of SARS-CoV-2 found in bats offers more evidence it evolved naturally – Cell Press
Original Article: A novel bat coronavirus closely related to SARS-CoV-2 contains natural insertions at the S1/S2 cleavage site of the spike protein – Current Biology
World Report: New Zealand Eliminates COVID-19
13 May, 2020 | 02:10h | UTCNew Zealand eliminates COVID-19 – The Lancet
See also: How New Zealand ‘eliminated’ Covid-19 after weeks of lockdown – CNN AND New Zealand has ‘effectively eliminated’ coronavirus. Here’s what they did right. – National Geographic AND Why New Zealand’s Coronavirus Elimination Strategy Is Unlikely to Work in Most Other Places – TIME
Study Commentary – Virus Wars: Return of Lopinavir/Ritonavir (Along with Ribavirin and Interferon)
13 May, 2020 | 02:12h | UTCVirus Wars: Return of Lopinavir/Ritonavir (along with ribavirin and interferon) – PulmCrit
Original Article: Triple Therapy Antiviral Combination Seems Promising for COVID-19 in Open-label, Randomized, Phase 2 Trial (study and commentaries)
Hydroxychloroquine in Patients with COVID-19: A Systematic Review and Meta-analysis
13 May, 2020 | 01:53h | UTC“While initial studies with hydroxychloroquine showed some ray of hope, recent studies that have emerged found either no benefit or a possible harm in COVID-19.”
Remdesivir in COVID-19: A Critical Review of Pharmacology, Pre-clinical and Clinical Studies
13 May, 2020 | 01:50h | UTC“While the first double-blind, randomized-controlled trial (DBRCT) found no significant benefit with remdesivir compared to placebo, preliminary reports from another DBRCT showed a significant faster recovery, without any difference in mortality.”
The FDA has Authorized the use of Remdesivir: But There’s no Good Evidence it Reduces Mortality in Covid-19
13 May, 2020 | 01:49h | UTC
Observational Study: Hydroxychloroquine, Azithromycin, or Both Not Associated with Lower In-hospital Mortality
12 May, 2020 | 03:39h | UTC
AIDS, TB and Malaria Set to Get Deadlier Due To Coronavirus
12 May, 2020 | 03:30h | UTCAIDS, TB And Malaria Set To Get Deadlier Due To Coronavirus – Forbes
Related: AIDS, TB And Malaria: Coronavirus Threatens The Endgame – Forbes AND The Potential Impact of the COVID-19 Epidemic on HIV, TB and Malaria in Low- and Middle-Income Countries – Imperial College London AND The potential impact of health service disruptions on the burden of malaria: a modelling analysis for countries in sub-Saharan Africa – World Health Organization AND The Potential Impact Of The Covid-19 Response On Tuberculosis In High-Burden Countries: A Modelling Analysis
WHO: COVID-19-Related Service Disruptions Could Cause Hundreds of Thousands of Extra Deaths from HIV
12 May, 2020 | 03:31h | UTCOriginal Preprints: Potential effects of disruption to HIV programmes in sub-Saharan Africa caused by COVID-19: results from multiple mathematical models AND Estimation of the potential effects of disruption to HIV programs in sub-Saharan Africa caused by COVID-19: results from multiple models APPENDIX
Related Commentary on Twitter
Health service & supply disruptions 🛑 during #COVID19 could cause half a million extra deaths from #HIV 📈 in sub-Saharan Africa.
Countries, communities & partners need to take action now❗️More in WHO & @UNAIDS joint statement: https://t.co/NPM8YTESN9 pic.twitter.com/mDEnEuLoEw
— World Health Organization (WHO) (@WHO) May 11, 2020
Updated WHO Guidance: Considerations for Public Health and Social Measures in the Workplace in the Context of COVID-19
12 May, 2020 | 03:34h | UTC
Related Commentary on Twitter
https://twitter.com/WHO/status/1259874331523518464
Study: Smartphone-based App for Tracking Self-reported Symptoms to Predict Potential COVID-19
12 May, 2020 | 03:25h | UTCReal-time tracking of self-reported symptoms to predict potential COVID-19 – Nature Medicine
Commentaries: New AI diagnostic can predict COVID-19 without testing – King’s College London AND Expert reaction to study looking at possibility of using real-time tracking of self-reported symptoms to predict potential COVID-19 without testing – Science Media Centre AND Coronavirus: research reveals way to predict infection – without a test – The Conversation AND Loss of smell and taste may actually be one of the clearest signs of COVID-19 – Science News
Richard Lehman’s Covid-19 Reviews—11 May 2020
12 May, 2020 | 03:22h | UTCRichard Lehman’s Covid-19 Reviews, 11 May 2020 – The BMJ Opinion
In this weekly round-up, Richard Lehman looks at a personal selection of articles of relevance to clinicians dealing with covid-19